Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Comprehensive Analysis Supports SERMs for Cutting Breast Cancer
Meta-analysis shows reduced incidence of breast cancer, especially in first five years of follow-up
This article is older than one year and is no longer available.

Copyright © 2013 HealthDay. All rights reserved.

May 1, 2016

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

FDA Reconsidering Training for Doctors Prescribing Opioids

Costs for Orally Administered Cancer Drugs Up Since 2000

First Commercial Zika Test Approved by FDA

Wide Variation in Health Care Costs Across the U.S.

Generic Crestor Approved by FDA

Guidelines Developed for Management of Atopic Dermatitis